Navigation Links
ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
Date:4/28/2008

Top-line Data Show Significant Improvements With ROX-828 In Migraine Pain

And Related Symptoms For Up to 48 Hours Vs. Placebo

MENLO PARK, Calif., April 28 /PRNewswire/ -- ROXRO PHARMA, Inc. today announced positive top-line data from a clinical study of the company's novel investigational intranasal pain reliever in the treatment of migraine and related symptoms.

The placebo-controlled proof of concept study evaluated the efficacy and safety of ROX-828, an intranasal formulation of the non-steroidal anti-inflammatory (NSAID) pain reliever ketorolac. Conducted at 17 sites in Germany and Finland, the trial involved 68 patients who received ROX-828 and 72 patients who received placebo. The study was conducted on an out-patient basis, with participants instructed to self-administer one dose of study drug when they experienced a migraine attack.

"While in-depth analysis of the data is currently under way, we are very excited about the positive response to ROX-828 among patients suffering from migraine," said ROXRO's Chief Scientific Officer Roger Whiting. "This is a condition for which rapid onset of action is very important, and we believe this novel nasal formulation of ROX-828 may offer a meaningful advantage for patients."

Migraine is a common recurring condition marked by severe, disabling headaches that are often accompanied by nausea and vomiting. Up to 17 percent of women and 6 percent of men suffer from migraines, which can last as long as 72 hours if untreated and have a significant impact on quality of life and productivity. Current treatment options include oral NSAIDs and triptan pain relievers, yet neither is either suitable or effective for all migraine sufferers.

"Treating migraine with a potent NSAID in a nasal spray is a sound scientific approach," said Dr. Volker Pfaffenrath, neurology specialist and principal study investigator in Germany. "With this novel mode of NSAID administration and ability to
'/>"/>

SOURCE ROXRO PHARMA, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015   InspireMD, Inc.  ("InspireMD" or the ... systems ("EPS"), today announced that it has entered into ... million shares of common stock and warrants to purchase ... in a public offering.  The common stock will be ... share, and each purchaser will receive a warrant to ...
(Date:3/4/2015)... Israël, 4 mars 2015 /PRNewswire/ ... (« RedHill » ou la « Société »), une ... sur les spécialités pharmaceutiques administrés ... stade clinique avancé pour les ... notamment les cancers gastro-intestinaux, a ...
(Date:3/4/2015)... -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced today ... at the Ritz-Carlton at Laguna Niguel, California ... Arthur S. Przybyl , President and CEO, will give the ... ANI,s website at www.anipharmaceuticals.com . Mr. Przybyl,s presentation will ... available through the link through June 7, 2015. ...
Breaking Medicine Technology:InspireMD Announces Public Offering for Approximately $13.5 Million 2InspireMD Announces Public Offering for Approximately $13.5 Million 3InspireMD Announces Public Offering for Approximately $13.5 Million 4RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 2RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 3RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 4RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 5ANI Pharmaceuticals To Present At 27th Annual ROTH Conference 2
... YORK, Jan. 12, 2011 NeoStem, Inc. (NYSE Amex: ... company with operations in the U.S. and China, today announced ... present on Wednesday, January 12, 2011 at the OneMedForum 2011 ... at 11:00 AM PST. Both events will be held in ...
... InstaCare Corp. (OTC Bulletin Board:  ISCR) a ... testing products for the chronically ill, a leading ... and a leading developer of revolutionary cell phone ... company,s Board of Directors has received the initial ...
Cached Medicine Technology:NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011 2NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011 3InstaCare Corp. Announces 2011 Genstrip Guidance Report Penned by William Walling, CFA 2
(Date:3/4/2015)... The defibrillators report provides insights into the growth ... the global market is expected to grow at a ... by 2019. It expects the emerging markets to provide ... established players in the market. , According to the ... at the highest CAGR during the next five years. ...
(Date:3/4/2015)... San Jose, California (PRWEB) March 04, 2015 ... rapidly becoming a worrisome public health issue worldwide. The ... a major economic and social burden in both developed ... cases globally is projected to rise to 1.5 billion, ... About 75% of these patients are forecast to come ...
(Date:3/4/2015)... Developers of FCPX plugins and theme templates ... Final Cut Pro X entitled FCPX Overlays Lens Dirt from ... total control over 6k lens dirt overlays inside Final Cut ... “FCPX Overlays Lens Dirt was professionally designed to add level ... FCPX Overlays Lens Dirt from Pixel Film Studios brings FCPX ...
(Date:3/4/2015)... March 04, 2015 The medical device ... whose management forgot – or ignored or didn't know ... the market based on physician input before proceeding to ... more specifically, founders – become so enamored of an ... question: Will physicians use the device?” says Dr. ...
(Date:3/3/2015)... On February 24, 2015, a Toledo, Ohio homeowner ... Court for the Northern District of Ohio against mortgage ... companies Balboa, QBE, and Newport Management. (See Amended Complaint ... The Plaintiff, a Ms. Dolores Gorsuch, says her mortgage ... buy too much insurance at rates that were too ...
Breaking Medicine News(10 mins):Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4Health News:Pixel Film Studios released a New Overlay Plugin entitled FCPX Overlays Lens Dirt Exclusively for Final Cut Pro X users 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2
... or purchase. , ... New York, ... a global leader in electronic content delivery solutions, today announced ... e-book portal using iPublishCentral ( www.ipublishcentral.com ), an easy-to-implement, cost-effective, ...
... Online health publisher, Healthcommunities.com, Inc., announces recent additions to urologychannel.com, ... in the extensive STD information section, will help ... plans and prevent STD complications. , ... ...
... Under counter ionizer converts to counter top for travel use. , ... Carlsbad, CA (PRWEB) ... mineral water at home or in the office has become a lot ... Ionizers., , , , ,The company today announced the availability of its enhanced ...
... of Spinal Muscular Atrophy has just launched a new Medical ... one of the most highly respected bodies of SMA medical ... proactive, creative, and collaborative leadership on issues that improve the ... new Council will focus on educating families, health care providers, ...
... Attorney General Eric Holder and Health and Human Services Secretary Kathleen ... protect taxpayer dollars on WEDNESDAY, MAY 20, ... Attorney General Eric Holder , Secretary Kathleen Sebelius WHAT: ... 20, 2009 , 1:00 P.M. ET WHERE: ...
... Democrats advance patient-centered CERWASHINGTON, May 19 ... Members of the New Democrat Coalition, Tony Coelho, ... (PIPC), spoke with reporters and announced PIPC,s support ... bill represents an important step forward for patients ...
Cached Medicine News:Health News:American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy 2Health News:American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy 3Health News:Valuable New Resources for Treating Sexually Transmitted Disease (STD) 2Health News:Valuable New Resources for Treating Sexually Transmitted Disease (STD) 3Health News:Life Ionizers Promotes Convenience and Healthy Lifestyles With New Convertible Water Ionizers Line 2Health News:Life Ionizers Promotes Convenience and Healthy Lifestyles With New Convertible Water Ionizers Line 3Health News:Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council 2Health News:Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council 3Health News:PIPC Supports New Comparative Effectiveness Research (CER) Bill 2
... The Vision5L Digital ... 5- or 7-lead, ... a signal preview,screen. ... using a compact,flash ...
The Atria 6100 delivers the highest level of clinical performance while incorporating cutting-edge technology to streamline clinic workflow. It offers timely, high-quality, and accurate ECG results c...
... CSV-1000CVA test face is used to evaluate both ... levels (high, 25% and 12.5%) of LogMAR acuity ... face as well as the two spatial frequencies ... most widely used for cataract documentation because eye ...
... is used widely for screening refractive surgery ... from 20/10 to 20/100 and one row ... ,The patient can be easily screened in ... contrast sensitivity. If a contrast sensitivity deficit ...
Medicine Products: